ANMI 1.82

ANMI SA is an API supplier for radiometals labeled radiopharmaceuticals and a global service provider in the nuclear medicine field field located in Liège, Belgium.

ANMI has developed innovative solutions to facilitate the synthesis of these theranostic radiopharmaceuticals and to ease their daily production in hospitals. These solutions are scalable and adaptable to a large range of peptide-based and non peptide-based radiopharmaceutical precursors.

The company expertise based on a strong market and regulatory knowledge of the nuclear medicine area can provide premium quality product and services.

ANMI vision is focus on increasing patient access to new highly specific theranostic radiopharmaceuticals through straight forward and cost effective production processes.